Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822396 | 0.86 | MAPT (0.67) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL29930756 | 0.84 | MAPT (0.41) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL6738675 | 0.84 | TSHR (0.43) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL996843 | 0.82 | KDM4E (0.44) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL822246 | 0.82 | MAPT (0.74) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL821850 | 0.82 | MAPT (0.81) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL451461 | 0.82 | — | — | |
| SCHEMBL6355099 | 0.81 | MAPT (0.39) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL11367005 | 0.80 | MAPT (0.60) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL822254 | 0.80 | MAPT (0.85) | MAPTLMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961448-B2 | Acid stabilization of quantum dot-resin concentrates and premixes | NANOSYS, INC. (US) | 2021-03-30 | — | — | US | claimed |
| WO-2018226654-A1 | ACID STABILIZATION OF QUANTUM DOT-RESIN CONCENTRATES AND PREMIXES | SMITH AUSTIN (US) | 2018-12-13 | — | — | WO | claimed |
| US-20180345638-A1 | ACID STABILIZATION OF QUANTUM DOT-RESIN CONCENTRATES AND PREMIXES | NANOSYS, INC. (US) | 2018-12-06 | — | — | US | claimed |
| US-9894946-B2 | Method for modifying the surface of an elastomer product | SEMPERIT AKTIENGESELLSCHAFT HOLDING (AT) | 2018-02-20 | — | — | US | claimed |
| EP-2719720-B1 | Method for modifying the surface of an elastomer product | SEMPERIT AG HOLDING (AT) | 2015-08-12 | — | — | EP | claimed |
| US-9056954-B2 | Cathodic electrocoating compositions | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2015-06-16 | — | — | US | claimed |
| EP-2719720-A1 | Method for modifying the surface of an elastomer product | Semperit Aktiengesellschaft Holding (AT) | 2014-04-16 | — | — | EP | claimed |
| US-20140096307-A1 | METHOD FOR MODIFYING THE SURFACE OF AN ELASTOMER PRODUCT | SEMPERIT AKTIENGESELLSCHAFT HOLDING (AT) | 2014-04-10 | — | — | US | claimed |
| US-20130146466-A1 | CATHODIC ELECTROCOATING COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | US | claimed |
| US-8440736-B2 | Photocuable thiol-ene low gas permeability membranes | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2013-05-14 | — | — | US | claimed |
| US-20090253805-A1 | Photocurable Thiol-Ene Low Gas Permeability Membranes | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2009-10-08 | — | — | US | claimed |
| US-12043731-B2 | Use of polyvinylacetate polymers or copolymers to increase the viscosity of the isocyanate component of a two-component curable polymeric system | HENKEL AG & CO. KGAA (DE) | 2024-07-23 | — | — | US | disclosed |
| WO-2024147917-A1 | DIELECTRIC FILM FORMING COMPOSITION CONTAINING ACYL GERMANIUM COMPOUND | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024141334-A1 | THIOL MASTERBATCH COMPOSITIONS AND METHODS OF PREPARING ULTRAVIOLET-CURABLE COMPOSITIONS | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | disclosed |
| EP-4393990-A1 | THIOL MASTERBATCH COMPOSITIONS AND METHODS OF PREPARING ULTRAVIOLET-CURABLE COMPOSITIONS | ARKEMA FRANCE (FR) | 2024-07-03 | — | — | EP | disclosed |
| WO-2011140519-A2 | IN VIVO GELLING PHARMACEUTICAL PRE-FORMULATION | MEDICUS BIOSCIENCES, LLC (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20110195237-A1 | SYSTEM AND RESIN FOR RAPID PROTOTYPING | HUNTSMAN INTERNATIONAL LLC (US) | 2011-08-11 | — | — | US | disclosed |
| EP-2346672-A1 | SYSTEM AND RESIN FOR RAPID PROTOTYPING | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010043463-A1 | SYSTEM AND RESIN FOR RAPID PROTOTYPING | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2010-04-22 | — | — | WO | disclosed |
| US-20090253805-A1 | Photocurable Thiol-Ene Low Gas Permeability Membranes | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253805-A1 | Photocurable Thiol-Ene Low Gas Permeability Membranes | ESD, TMT1A, GPX4 | MAPT 2934/4885LMNA 3519/4885KDM4E 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.